GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Terumo Corp (OTCPK:TRUMY) » Definitions » Cyclically Adjusted Revenue per Share

Terumo (Terumo) Cyclically Adjusted Revenue per Share : $3.04 (As of Mar. 2024)


View and export this data going back to 2008. Start your Free Trial

What is Terumo Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Terumo's adjusted revenue per share for the three months ended in Mar. 2024 was $1.074. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is $3.04 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Terumo's average Cyclically Adjusted Revenue Growth Rate was 9.50% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 8.90% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 7.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Terumo was 8.90% per year. The lowest was 6.20% per year. And the median was 6.30% per year.

As of today (2024-06-09), Terumo's current stock price is $17.16. Terumo's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was $3.04. Terumo's Cyclically Adjusted PS Ratio of today is 5.64.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Terumo was 7.83. The lowest was 3.51. And the median was 5.34.


Terumo Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Terumo's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Terumo Cyclically Adjusted Revenue per Share Chart

Terumo Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.09 3.15 3.03 3.09 3.04

Terumo Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.09 2.92 2.87 3.10 3.04

Competitive Comparison of Terumo's Cyclically Adjusted Revenue per Share

For the Medical Instruments & Supplies subindustry, Terumo's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Terumo's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Terumo's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Terumo's Cyclically Adjusted PS Ratio falls into.



Terumo Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Terumo's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=1.074/107.2000*107.2000
=1.074

Current CPI (Mar. 2024) = 107.2000.

Terumo Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 0.741 98.000 0.811
201409 0.725 98.500 0.789
201412 0.702 97.900 0.769
201503 0.647 97.900 0.708
201506 0.642 98.400 0.699
201509 0.674 98.500 0.734
201512 0.700 98.100 0.765
201603 0.723 97.900 0.792
201606 0.760 98.100 0.830
201609 0.761 98.000 0.832
201612 0.716 98.400 0.780
201703 0.813 98.100 0.888
201706 0.831 98.500 0.904
201709 0.867 98.800 0.941
201712 0.892 99.400 0.962
201803 0.939 99.200 1.015
201806 0.857 99.200 0.926
201809 0.833 99.900 0.894
201812 0.934 99.700 1.004
201903 0.926 99.700 0.996
201906 0.933 99.800 1.002
201909 0.950 100.100 1.017
201912 0.986 100.500 1.052
202003 0.974 100.300 1.041
202006 0.806 99.900 0.865
202009 0.951 99.900 1.020
202012 1.053 99.300 1.137
202103 1.004 99.900 1.077
202106 1.031 99.500 1.111
202109 1.037 100.100 1.111
202112 1.038 100.100 1.112
202203 1.002 101.100 1.062
202206 0.973 101.800 1.025
202209 0.952 103.100 0.990
202212 1.065 104.100 1.097
202303 1.015 104.400 1.042
202306 1.022 105.200 1.041
202309 1.038 106.200 1.048
202312 1.116 106.800 1.120
202403 1.074 107.200 1.074

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Terumo  (OTCPK:TRUMY) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Terumo's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=17.16/3.04
=5.64

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Terumo was 7.83. The lowest was 3.51. And the median was 5.34.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Terumo Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Terumo's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Terumo (Terumo) Business Description

Industry
Traded in Other Exchanges
Address
2-44-1 Hatagaya, Shibuya-ku, Tokyo, JPN, 151-0072
Terumo Corp manufactures and sells medical products and equipment. The firm has three main businesses: blood management, cardiac and vascular, and general hospital. The cardiac and vascular business generates the largest proportion of revenue and sells cardiac and endovascular interventional therapies, cardiovascular surgical systems, neurovascular products, and vascular graft products. The general hospital business includes diabetes management, consumer healthcare, drug and device technologies, and general hospital products. The blood management business sells blood component, therapeutic apheresis, and cellular technologies. Terumo generates the majority of its revenue in Asia, with Japan contributing the largest proportion of Asian revenue.

Terumo (Terumo) Headlines

From GuruFocus

Matthews Japan Fund Picks Up 5 Stocks in 2nd Quarter

By Yamil Berard Yamil Berard 08-08-2018

Terumo Enters 100th Anniversary Year

By PRNewswire PRNewswire 01-05-2021

MicroVention Announces FDA Clearance For Thrombectomy Device

By PRNewswire PRNewswire 06-12-2018